Amesite Inc. Reports Annual Meeting Results; Approves Equity Plan Increase

What Happened

• Amesite Inc. (AMST) held its annual meeting on July 13, 2026 and filed an 8-K reporting the results. Stockholders approved an amendment to the company’s 2018 Equity Incentive Plan to add 1,000,000 shares overall and to increase by 1,000,000 the number of shares available for issuance upon exercise of incentive stock options.
• At the meeting shareholders also elected Class II directors Ann Marie Sastry, Ph.D., and Barbie Brewer for three-year terms, ratified Novogradac & Company LLP as the company’s independent registered public accounting firm, and approved, under Nasdaq Listing Rule 5635(d), the issuance of 1,393,732 shares upon exercise of Series A-1 warrants and 1,393,732 shares upon exercise of Series A-2 warrants.

Key Details

• Record date: May 22, 2026; outstanding common shares: 5,852,985. Shares represented at the meeting: 2,321,797 (~40%), constituting a quorum.
• Equity plan amendment vote: For 1,148,268; Against 335,287; Abstentions 9,686. Amendment increases plan shares by 1,000,000 and ISOs by 1,000,000.
• Director election (votes shown as For / Withheld / Broker non-votes): Ann Marie Sastry 1,287,736 / 205,505 / 828,556; Barbie Brewer 1,286,513 / 206,728 / 828,556.
• Warrant issuance approval vote: For 1,216,551; Against 130,855; Abstentions 145,835. Approved potential issuance totals 1,393,732 shares (Series A-1) and 1,393,732 shares (Series A-2) — 2,787,464 shares if both series are exercised.

Why It Matters

• The equity plan increase and the approved warrant issuances can dilute existing shareholders if shares are granted or warrants exercised; the filing gives the exact share amounts so investors can measure potential dilution.
• Re-election of directors and ratification of the auditor maintain board continuity and the company’s chosen accounting oversight, both of which are routine governance matters investors watch for stability and transparency.